United States Environmental Protection Agency
Integrated Risk Information System Logo


Ally
CASRN 74223-64-6

Contents


0288
Ally; CASRN 74223-64-6  


Health assessment information on a chemical substance is included in IRIS only 
after a comprehensive review of chronic toxicity data by U.S. EPA health 
scientists from several Program Offices and the Office of Research and 
Development.  The summaries presented in Sections I and II represent a 
consensus reached in the review process.  Background information and 
explanations of the methods used to derive the values given in IRIS are 
provided in the Background Documents. 


STATUS OF DATA FOR  Ally

File On-Line 06/30/1988

Category (section)                           Status      Last Revised
-----------------------------------------    --------    ------------

Oral RfD Assessment (I.A.)                   on-line       06/30/1988

Inhalation RfC Assessment (I.B.)             no data     

Carcinogenicity Assessment (II.)             no data     



_I. CHRONIC HEALTH HAZARD ASSESSMENTS FOR NONCARCINOGENIC EFFECTS __I.A. REFERENCE DOSE FOR CHRONIC ORAL EXPOSURE (RfD) Substance Name -- Ally CASRN -- 74223-64-6 Last Revised -- 06/30/1988 The oral Reference Dose (RfD) is based on the assumption that thresholds exist for certain toxic effects such as cellular necrosis. It is expressed in units of mg/kg-day. In general, the RfD is an estimate (with uncertainty spanning perhaps an order of magnitude) of a daily exposure to the human population (including sensitive subgroups) that is likely to be without an appreciable risk of deleterious effects during a lifetime. Please refer to the Background Document for an elaboration of these concepts. RfDs can also be derived for the noncarcinogenic health effects of substances that are also carcinogens. Therefore, it is essential to refer to other sources of information concerning the carcinogenicity of this substance. If the U.S. EPA has evaluated this substance for potential human carcinogenicity, a summary of that evaluation will be contained in Section II of this file. ___I.A.1. ORAL RfD SUMMARY Critical Effect Experimental Doses* UF MF RfD -------------------- ----------------------- ----- --- --------- Decreased body NOEL: 500 ppm (25 100 1 2.5E-1 weight mg/kg/day) mg/kg/day 2-Year Rat Feeding/ LEL: 5000 ppm (250 Oncogenicity Study mg/kg/day) duPont, 1985a
*Conversion Factors: 1 ppm = 0.05 mg/kg/day (assumed rat food consumption) ___I.A.2. PRINCIPAL AND SUPPORTING STUDIES (ORAL RfD) E.I. duPont de Nemours and Company, Inc. 1985a. MRID No. 00125931, 00151029, 00154477. Available from EPA. Write to FOI, EPA, Washington, DC 20460. Groups of 90 male and 90 female Sprague-Dawley rats were fed diets containing the test material at levels of 0, 5, 25, 500, or 5000 ppm for 2 years. Twenty animals/sex/group were removed from the chronic study at 11 weeks for the reproductive phase of the study and put back into the chronic phase at week 32. The LEL for systemic chronic toxicity is considered to be 5000 ppm based on body weights. The NOEL has been determined to be 500 ppm. Groups of 19 or 20 female rabbits were administered 2 mL portions of ally in 0.5% aqueous methocel by gavage during days 6 to 18 of gestation, at doses of either 25, 100, 300, or 700 mg/kg/day. Developmental toxicity was not demonstrated. Maternal toxicity was shown by a dose-related increase in mortality and decrease in body weight at doses of 100 mg/kg/day or higher. The 25 mg/kg/day dose was a NOEL. These results are consistent with those of the primary study. ___I.A.3. UNCERTAINTY AND MODIFYING FACTORS (ORAL RfD) UF -- An uncertainty factor of 100 was used to account for the inter- and intraspecies differences. MF -- None ___I.A.4. ADDITIONAL COMMENTS (ORAL RfD) Data Considered for Establishing the RfD: 1) 2-Year Feeding (oncogenic) - rat: Principal study - see previous description; core grade minimum 2) 1-Year Feeding - dog: NOEL=5000 ppm (125 mg/kg/day) (no effect at the HDT); core grade minimum (duPont, 1984) 3) 2-Generation Reproduction - rat: Maternal NOEL=500 ppm (25 mg/kg/day); Maternal LEL=5000 ppm (250 mg/kg/day) (decreased weight gain); Reproductive NOEL=5000 ppm (HDT); Fetotoxic NOEL=5000 ppm (HDT); core grade minimum (duPont, 1985b) 4) Teratology - rat: Teratogenic NOEL=1000 mg/kg/day (HDT); Fetotoxic NOEL=1000 mg/kg/day; Maternal toxic NOEL=none; Maternal toxic LEL=40 mg/kg/day (hyperactivity, ungroomed coat); core grade minimum (duPont, 1982) 5) Teratology - rabbit: Maternal toxic NOEL=25 mg/kg/day; Maternal toxic LEL=100 mg/kg/day (decreased weight gain and death); Teratogenic NOEL=700 mg/kg/day; Fetotoxic NOEL=700 mg/kg/day (HDT); core grade minimum (duPont, 1985c) Data Gap(s): None ___I.A.5. CONFIDENCE IN THE ORAL RfD Study -- High Data Base -- High RfD -- High The critical study is of good quality and and is given a high confidence rating. Additional studies are also of good quality; therefore, the data base is given a high confidence rating. High confidence in the RfD follows. ___I.A.6. EPA DOCUMENTATION AND REVIEW OF THE ORAL RfD Source Document -- This assessment is not presented in any existing U.S. EPA document. Other EPA Documentation -- Pesticide Registration Files Agency Work Group Review -- 04/22/1986, 08/12/1987 Verification Date -- 08/12/1987 ___I.A.7. EPA CONTACTS (ORAL RfD) Please contact the Risk Information Hotline for all questions concerning this assessment or IRIS, in general, at (513)569-7254 (phone), (513)569-7159 (FAX) or RIH.IRIS@EPAMAIL.EPA.GOV (internet address).
__I.B. REFERENCE CONCENTRATION FOR CHRONIC INHALATION EXPOSURE (RfC) Substance Name -- Ally CASRN -- 74223-64-6 Not available at this time.
_II. CARCINOGENICITY ASSESSMENT FOR LIFETIME EXPOSURE Substance Name -- Ally CASRN -- 74223-64-6 This substance/agent has not undergone a complete evaluation and determination under US EPA's IRIS program for evidence of human carcinogenic potential.
_VI. BIBLIOGRAPHY Substance Name -- Ally CASRN -- 74223-64-6 Last Revised -- 11/01/1989 __VI.A. ORAL RfD REFERENCES E.I. duPont de Nemours and Company, Inc. 1982. MRID No. 00125835. Available from EPA. Write to FOI, EPA, Washington, DC 20460. E.I. duPont de Nemours and Company, Inc. 1984. MRID No. 00141821. Available from EPA. Write to FOI, EPA, Washington, DC 20460. E.I. duPont de Nemours and Company, Inc. 1985a. MRID No. 00125931, 00151029, 00154477. Available from EPA. Write to FOI, EPA, Washington, DC 20460. E.I. duPont de Nemours and Company, Inc. 1985b. MRID No. 00151028. Available from EPA. Write to FOI, EPA, Washington, DC 20460. E.I. duPont de Nemours and Company, Inc. 1985c. MRID No. 00151028. Available from EPA. Write to FOI, EPA, Washington, DC 20460.
__VI.B. INHALATION RfD REFERENCES None
__VI.C. CARCINOGENICITY ASSESSMENT REFERENCES None
_VII. REVISION HISTORY Substance Name -- Ally CASRN -- 74223-64-6 -------- -------- -------------------------------------------------------- Date Section Description -------- -------- -------------------------------------------------------- 11/01/1989 VI. Bibliography on-line
VIII. SYNONYMS Substance Name -- Ally CASRN -- 74223-64-6 Last Revised -- 06/30/1988 74223-64-6 Ally Benzoic acid, 2-(((((4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino)- carbonyl) amino)sulfonyl)-, methyl ester Benzoic acid, 2-(((((4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino)carbonyl) amino)sulfonyl)-, methyl ester (9CI) Caswell No. 419H DPD 63760M DPX 6376 DPX T6376 EPA Pesticide Chemical Code 122010 Gropper Methyl-2-((((4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino)carbonyl)amino) sulfonyl)benzoate Metsulfuron-methyl Metsulfuron methyl ester [ANSI]



IRIS Home Page Substance File List
Comments on the IRIS web site Search the IRIS database National Center for Environmental Assessment Office of Research and Development's Home Page EPA's Home Page


Last updated: 5 May 1998
URL: http://www.epa.gov/iris/SUBST/0288.HTM